关注
Christa Buecker
Christa Buecker
在 univie.ac.at 的电子邮件经过验证
标题
引用次数
引用次数
年份
Reorganization of enhancer patterns in transition from naive to primed pluripotency
C Buecker, R Srinivasan, Z Wu, E Calo, D Acampora, T Faial, A Simeone, ...
Cell stem cell 14 (6), 838-853, 2014
4992014
Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities
B Crosas, J Hanna, DS Kirkpatrick, DP Zhang, Y Tone, NA Hathaway, ...
Cell 127 (7), 1401-1413, 2006
3682006
Enhancers as information integration hubs in development: lessons from genomics
C Buecker, J Wysocka
Trends in Genetics 28 (6), 276-284, 2012
3332012
A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells
C Buecker, HH Chen, JM Polo, L Daheron, L Bu, TS Barakat, P Okwieka, ...
Cell stem cell 6 (6), 535-546, 2010
2722010
Pluripotent state transitions coordinate morphogenesis in mouse and human embryos
MN Shahbazi, A Scialdone, N Skorupska, A Weberling, G Recher, M Zhu, ...
Nature 552 (7684), 239-243, 2017
2312017
Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells
R Samuel, L Daheron, S Liao, T Vardam, WS Kamoun, A Batista, ...
Proceedings of the National Academy of Sciences 110 (31), 12774-12779, 2013
1832013
DAZL limits pluripotency, differentiation, and apoptosis in developing primordial germ cells
HH Chen, M Welling, DB Bloch, J Muñoz, E Mientjes, X Chen, C Tramp, ...
Stem cell reports 3 (5), 892-904, 2014
1052014
Temporal dissection of an enhancer cluster reveals distinct temporal and functional contributions of individual elements
HF Thomas, E Kotova, S Jayaram, A Pilz, M Romeike, A Lackner, T Penz, ...
Molecular Cell 81 (5), 969-982. e13, 2021
612021
Different flavors of pluripotency, molecular mechanisms, and practical implications
C Buecker, N Geijsen
Cell stem cell 7 (5), 559-564, 2010
522010
An ES-like pluripotent state in FGF-dependent murine iPS cells
B Di Stefano, C Buecker, F Ungaro, A Prigione, HH Chen, M Welling, ...
PLoS One 5 (12), e16092, 2010
262010
NMD is required for timely cell fate transitions by fine-tuning gene expression and regulating translation
M Huth, L Santini, E Galimberti, J Ramesmayer, F Titz-Teixeira, R Sehlke, ...
Genes & Development 36 (5-6), 348-367, 2022
212022
Methods and compositions for homologous recombination in human cells
N Geijsen, C Buecker
US Patent 8,524,498, 2013
122013
Transient upregulation of IRF1 during exit from naive pluripotency confers viral protection
M Romeike, S Spach, M Huber, S Feng, G Vainorius, U Elling, ...
EMBO reports 23 (9), e55375, 2022
62022
What is an enhancer?
HF Thomas, C Buecker
Bioessays 45 (10), 2300044, 2023
42023
iPSCs: 10 years and counting
SK Kim, K Baldwin, S Gao, C Bücker, M Parmar, N Benvenisty
Cell 165 (5), 1041-1042, 2016
32016
The asynchrony in the exit from naive pluripotency cannot be explained by differences in the cell cycle phase
S Jayaram, M Romeike, C Buecker
bioRxiv, 2023.09. 15.557731, 2023
22023
NMD is required for timely cell fate transitions by fine-tuning gene expression and controlling translation
E Galimberti, R Sehlke, M Huth, M Garmhausen, M Romeike, ...
bioRxiv, 2020.07. 07.180133, 2020
12020
Detailed temporal dissection of an enhancer cluster reveals two distinct roles for individual elements
H Thomas, E Kotova, A Pilz, M Romeike, A Lackner, C Bock, M Leeb, ...
bioRxiv, 2020.05. 06.080564, 2020
12020
Erratum: Pluripotent state transitions coordinate morphogenesis in mouse and human embryos
MN Shahbazi, A Scialdone, N Skorupska, A Weberling, G Recher, M Zhu, ...
Nature 555 (7694), 126-126, 2018
12018
Methods and compositions for homologous recombination in human cells
N Geijsen, C Buecker
US Patent App. 13/968,852, 2014
12014
系统目前无法执行此操作,请稍后再试。
文章 1–20